5.50
-0.12 (-2.14%)
-0.12 (-2.14%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| InflaRx NV | IFRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.12 | -2.14% | 5.50 | 08:41:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.62 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 5.55 | 5.70 | 0.15 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 3 | 600 | 411,854 | 2.52 - 9.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:00:03 | formt | 500 | $ 5.50 | USD |
InflaRx NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 155.26M | 28.23M | 23.88M | $ - | $ - | -2.36 | -3.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
InflaRx NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IFRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.01 | 6.07 | 5.38 | 5.70 | 260,014 | -0.51 | -8.49% |
| 1 Month | 5.06 | 6.88 | 4.6289 | 5.74 | 371,418 | 0.44 | 8.7% |
| 3 Months | 4.13 | 6.88 | 3.77 | 5.03 | 289,609 | 1.37 | 33.17% |
| 6 Months | 5.15 | 6.88 | 3.50 | 4.75 | 380,754 | 0.35 | 6.8% |
| 1 Year | 3.49 | 9.70 | 2.52 | 5.44 | 722,589 | 2.01 | 57.59% |
| 3 Years | 22.66 | 53.10 | 2.17 | 6.84 | 512,190 | -17.16 | -75.73% |
| 5 Years | 15.19 | 53.10 | 2.17 | 6.99 | 487,546 | -9.69 | -63.79% |
InflaRx NV Description
| InflaRx NV is a clinical-stage biopharmaceutical company is focused on applying proprietary anti-C5a technology to discover and develop specific inhibitors of the complement activation factor known as C5a. The lead product candidate of the company is IFX-1, which is developed for the treatment of Hidradenitis Suppurativa, a rare and chronic debilitating systemic inflammatory skin disease. The company's proprietary anti-C5a technology is an inflammatory mediator involved in the progression of a variety of autoimmune and other inflammatory diseases. It is also developing IFX-1 for the treatment of AAV, a life-threatening autoimmune disease associated with powerful inflammatory flares that impair kidney function and lead to fatal organ dysfunction. |
